Galapagos NV
GLPG
#4563
Rank
NZ$3.65 B
Marketcap
NZ$54.68
Share price
-0.57%
Change (1 day)
19.35%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$15.24 Million

According to Galapagos NV's latest financial reports the company's total debt is NZ$15.24 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$21.62 M28.94%
2023-12-31NZ$16.77 M-54.67%
2022-12-31NZ$37 M-16.91%
2021-12-31NZ$44.53 M-11.25%
2020-12-31NZ$50.17 M18.84%
2019-12-31NZ$42.22 M
2018-12-31N/A-100%
2017-12-31NZ$0.01 M-84.11%
2016-12-31NZ$0.09 M-47.93%
2015-12-31NZ$0.18 M-29.13%
2014-12-31NZ$0.25 M-60.75%
2013-12-31NZ$0.66 M1.42%
2012-12-31NZ$0.65 M-55.32%
2011-12-31NZ$1.45 M-32.09%
2010-12-31NZ$2.14 M-26.67%
2009-12-31NZ$2.92 M-27.93%
2008-12-31NZ$4.06 M-51.22%
2007-12-31NZ$8.32 M-42.76%
2006-12-31NZ$14.54 M5.35%
2005-12-31NZ$13.8 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
NZ$56.48 B 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$79.27 B 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$44.19 B 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
NZ$118.99 B 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ$0.11 B 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$22.40 B 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.55 B 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$41.30 B 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$71.61 B 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA